InsiderClue
Insiders · Profile

Akinsanya Karen

See Remarks at Schrodinger. Filing since 12 Aug 2020. CIK 0001797672

Company
Date
Role
Action
Shares
Amount
Of holding
SDGR Schrodinger, Inc.
17 Sep 2026
See Remarks
Sold on a plan
31,599
$927.97K
31.1%
SDGR Schrodinger, Inc.
5 Mar 2026
See Remarks
Sold on a plan
1,366
$17.63K
1.9%
SDGR Schrodinger, Inc.
2 Mar 2026
See Remarks
Sold on a plan
2,206
$26.45K
3.0%
SDGR Schrodinger, Inc.
14 Apr 2025
President of R&D, Therapeutics
Sold on a plan
16,723
$419.57K
51.7%
SDGR Schrodinger, Inc.
15 Oct 2021
See Remarks
Sold, plan not stated
1,393
$77.66K
100%
SDGR Schrodinger, Inc.
15 Sep 2021
See Remarks
Sold, plan not stated
1,394
$85.22K
100%
SDGR Schrodinger, Inc.
16 Aug 2021
See Remarks
Sold, plan not stated
37,738
$2.18M
100%
SDGR Schrodinger, Inc.
8 Jun 2021
See Remarks
Sold, plan not stated
10,242
$773.64K
100%
SDGR Schrodinger, Inc.
7 Jun 2021
See Remarks
Sold, plan not stated
6,479
$486.57K
100%
SDGR Schrodinger, Inc.
18 Dec 2020
See Remarks
Sold, plan not stated
13,377
$1.07M
100%
SDGR Schrodinger, Inc.
17 Aug 2020
See Remarks
Sold, plan not stated
3,344
$227.52K
100%
SDGR Schrodinger, Inc.
12 Aug 2020
See Remarks
Sold, plan not stated
20,065
$1.35M
100%
12 decisions on file.